Acuta Capital Partners’s Biomea Fusion BMEA Stock Holding History

Acuta Capital Partners’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,935	Closed	-$550K	–	43
2023 Q3	$550K	Sell	39,935 -65	-0.2%	-$1.17K	0.37%	35
2023 Q2	$878K	Buy	+40,000	New	+$1.25M	0.59%	30
2022 Q4	–	Sell	-1,000	Closed	-$10K	–	37
2022 Q3	$10K	Buy	+1,000	New	+$11.5K	﹤0.01%	47

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acuta Capital Partners's BMEA Position: Q4 2023 in Review

Acuta Capital Partners sold out of Biomea Fusion (BMEA) in Q4 2023, closing a stake of 39,935 shares — an estimated $550K sold.

Acuta Capital Partners first reported a position in BMEA in Q3 2022 and held it in 3 quarters. The position peaked at $878K in Q2 2023. 100 funds tracked by Wall St. Rank hold BMEA as of Q4 2023.

Acuta Capital Partners reported no remaining Biomea Fusion position as of Q4 2023 after selling out during the quarter.
Acuta Capital Partners sold 39,935 Biomea Fusion shares in Q4 2023, an estimated $550K.
Acuta Capital Partners first reported a position in Biomea Fusion in Q3 2022 and held it in 3 quarters.
Acuta Capital Partners's Biomea Fusion position peaked at $878K in Q2 2023.
100 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2023.

Based on Acuta Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.